Literature DB >> 21257838

Use of the triaxial microcatheter method in super-selective transcatheter arterial chemoembolisation for hepatocellular carcinoma.

M Shimohira1, H Ogino, T Kawai, A Kushita, M Watanabe, T Kawaguchi, K Kurono, Y Shibamoto.   

Abstract

OBJECTIVES: Transcatheter arterial chemoembolisation (TACE) has been widely used for inoperable hepatocellular carcinoma (HCC). Super-selective TACE is preferable to non-selective therapy, because it maximises the impact of treatment on the tumour while minimising damage to tumour-free liver parenchyma. It is therefore important to advance the catheter tip as close as possible in the feeding artery. There is now a new microcatheter with a 1.9-Fr tip with no taper, which can be inserted into a 2.7-Fr microcatheter. In this study we describe the new technique of using the two microcatheters called the triaxial microcatheter method.
METHODS: We evaluated 30 TACE procedures to investigate whether or not the catheter tip could be advanced closer to HCC with the triaxial microcatheter method than with previous TACE using a conventional microcatheter.
RESULTS: With conventional microcatheters, the level of embolisation was a lobar artery in 4 cases, segmental in 8 cases, subsegmental in 15 cases and sub-subsegmental in only 1 case. TACE could not be performed in two cases. When using the triaxial microcatheter method the level of embolisation was subsegmental in 8 cases, including 2 in which the level was the same as that with a conventional microcatheter, sub-subsegmental in 13 cases and more distal in 7 cases. In the two cases in which TACE could not be performed with the conventional microcatheter, it could be performed sufficiently using the new method. As a whole, in 28 of the 30 procedures (93%) we could successfully advance a catheter tip closer than with the previous TACE.
CONCLUSION: The triaxial microcatheter method appears to be useful.

Entities:  

Mesh:

Year:  2011        PMID: 21257838      PMCID: PMC3473862          DOI: 10.1259/bjr/26974088

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  10 in total

1.  Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.

Authors:  Kenichi Takayasu; Shigeki Arii; Iwao Ikai; Masao Omata; Kiwamu Okita; Takafumi Ichida; Yutaka Matsuyama; Yasuni Nakanuma; Masamichi Kojiro; Masatoshi Makuuchi; Yoshio Yamaoka
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

2.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

3.  Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma.

Authors:  H Uchida; H Ohishi; N Matsuo; K Nishimine; S Ohue; Y Nishimura; M Maeda; T Yoshioka
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Jun-Jul       Impact factor: 2.740

4.  Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?

Authors:  T Harada; K Matsuo; T Inoue; S Tamesue; T Inoue; H Nakamura
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

5.  Rising incidence of hepatocellular carcinoma in the United States.

Authors:  H B El-Serag; A C Mason
Journal:  N Engl J Med       Date:  1999-03-11       Impact factor: 91.245

6.  Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion.

Authors:  Y Yamashita; M Takahashi; Y Koga; R Saito; S Nanakawa; Y Hatanaka; N Sato; K Nakashima; J Urata; K Yoshizumi
Journal:  Cancer       Date:  1991-01-15       Impact factor: 6.860

7.  Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue.

Authors:  N Matsuo; H Uchida; K Nishimine; S Soda; M Oshima; H Nakano; N Nagano; Y Nishimura; T Yoshioka; Q Guo
Journal:  J Vasc Interv Radiol       Date:  1993 Jul-Aug       Impact factor: 3.464

Review 8.  Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization.

Authors:  O Matsui; M Kadoya; J Yoshikawa; T Gabata; K Arai; H Demachi; S Miyayama; T Takashima; M Unoura; K Kogayashi
Journal:  Radiology       Date:  1993-07       Impact factor: 11.105

9.  Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients.

Authors:  J P Bronowicki; D Vetter; F Dumas; K Boudjema; R Bader; A M Weiss; J J Wenger; P Boissel; M A Bigard; M Doffoel
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

10.  Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk.

Authors:  Nishita Kothary; Joshua L Weintraub; Jonathan Susman; John H Rundback
Journal:  J Vasc Interv Radiol       Date:  2007-12       Impact factor: 3.464

  10 in total
  4 in total

1.  A newly developed double lumen microballoon catheter with a side hole: initial experience of intraarterial infusion chemotherapy and/or embolization.

Authors:  Masamichi Koganemaru; Toshi Abe; Hiroshi Anai; Norimitsu Tanaka; Masaaki Nonoshita; Ryoji Iwamoto; Masashi Kusumoto; Asako Kuhara; Tomoko Kugiyama; Naofumi Hayabuchi
Journal:  Jpn J Radiol       Date:  2012-09-08       Impact factor: 2.374

2.  Triaxial system in bronchial arterial embolization for haemoptysis using N-butyl-2-cyanoacrylate.

Authors:  Masashi Shimohira; Takeshi Hashimoto; Saori Abematsu; Takuya Hashizume; Motoo Nakagawa; Yoshiyuki Ozawa; Keita Sakurai; Yuta Shibamoto
Journal:  Br J Radiol       Date:  2015-10-01       Impact factor: 3.039

3.  Triaxial system in re-embolization for recanalization of pulmonary arteriovenous malformations.

Authors:  Masashi Shimohira; Takuya Hashizume; Tatsuya Kawai; Masahiro Muto; Kengo Ohta; Kazushi Suzuki; Yuta Shibamoto
Journal:  Pol J Radiol       Date:  2015-02-07

4.  Electronically integrated microcatheters based on self-assembling polymer films.

Authors:  Boris Rivkin; Christian Becker; Balram Singh; Azaam Aziz; Farzin Akbar; Aleksandr Egunov; Dmitriy D Karnaushenko; Ronald Naumann; Rudolf Schäfer; Mariana Medina-Sánchez; Daniil Karnaushenko; Oliver G Schmidt
Journal:  Sci Adv       Date:  2021-12-17       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.